+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CytoDyn Inc - logo

CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. The company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has finished Phase 2 clinical trials with demonstrated antiviral activity in man. The company is based in Vancouver, Washington.

From
HIV Drugs Market Report 2025 - Product Thumbnail Image

HIV Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
COVID-19 Current Therapy Market Report 2025 - Product Thumbnail Image

COVID-19 Current Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
From
From
From
From
Licensing Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 1400 Pages
  • Global
From
From
From
Loading Indicator